You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Keywords provided by NS Pharma, Inc.:

Showing 1 - 25 of 8,404
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Paroxysmal Supraventricular Tachycardia Trial in Worldwide (Etripamil NS)

Active, not recruiting
  • Paroxysmal Supraventricular Tachycardia
  • Etripamil NS
  • Gilbert, Arizona
  • +123 more
Nov 21, 2022

Duchenne Muscular Dystrophy Trial in Portland (NS-089/NCNP-02)

Not yet recruiting
  • Duchenne Muscular Dystrophy
  • Portland, Oregon
    Shriners Hospital for Children
Aug 16, 2023

Tachycardia, Supraventricular, Paroxysmal Supraventricular Tachycardia Trial in China (Etripamil NS 70 mg, Placebo)

Recruiting
  • Tachycardia, Supraventricular
  • Paroxysmal Supraventricular Tachycardia
  • Etripamil NS 70 mg
  • Placebo
  • Beijing, Beijing, China
  • +43 more
Aug 16, 2022

Netherton Syndrome Trial in Paris (DS-2325a, Placebo)

Not yet recruiting
  • Netherton Syndrome
  • Paris, France
    Saint Louis Hospital
Jul 31, 2023

Duchenne Muscular Dystrophy Trial (NS-050/NCNP-03, Placebo)

Not yet recruiting
  • Duchenne Muscular Dystrophy
  • (no location specified)
Sep 19, 2023

Paroxysmal Supraventricular Tachycardia Trial (Etripamil NS)

Not yet recruiting
  • Paroxysmal Supraventricular Tachycardia
  • Etripamil NS
  • (no location specified)
Feb 28, 2023

Hypertension, Coronary Artery Disease Trial in Vadodara (Amlodipine Freeze-Dried Powder for Oral Solution 5 mg, Norvasc 5 mg

Active, not recruiting
  • Hypertension
  • Coronary Artery Disease
  • Amlodipine Freeze-Dried Powder for Oral Solution 5 mg
  • Norvasc 5 mg tablets of Pfizer Labs
  • Vadodara, Gujarat, India
    Accutest Research Laboratories (I) Pvt. Ltd.
Apr 10, 2023

Paroxysmal Supraventricular Tachycardia Trial in Canada, United States (Etripamil NS 70 mg, Aptar Pharma Nasal Spray Bidose

Enrolling by invitation
  • Paroxysmal Supraventricular Tachycardia
  • Etripamil NS 70 mg
  • Aptar Pharma Nasal Spray Bidose System
  • Little Rock, Arkansas
  • +13 more
Apr 1, 2022

Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome Trial (NS-229, Placebo)

Not yet recruiting
  • Eosinophilic Granulomatosis With Polyangiitis
  • Churg-Strauss Syndrome
  • (no location specified)
Sep 14, 2023

Duchenne Muscular Dystrophy Trial in Worldwide (Viltolarsen)

Enrolling by invitation
  • Duchenne Muscular Dystrophy
  • Westmead, Australia
  • +13 more
May 24, 2022

Pregnancy Related, Nausea Trial in Moscow (Doxylamine + Pyridoxine)

Recruiting
  • Pregnancy Related
  • Nausea
  • Doxylamine + Pyridoxine
  • Moscow, Russian Federation
    Llc "Certa Clinic"
Aug 9, 2022

Duchenne Muscular Dystrophy Trial in Canada, United States (NS-065/NCNP-01)

Completed
  • Duchenne Muscular Dystrophy
  • Sacramento, California
  • +5 more
Nov 23, 2021

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Worcester, Massachusetts
  • +16 more
Oct 31, 2022

Paroxysmal Supraventricular Tachycardia Trial in Canada, United States (Etripamil NS 70 mg, Aptar Pharma Nasal Spray Bidose

Completed
  • Paroxysmal Supraventricular Tachycardia
  • Etripamil NS 70 mg
  • Aptar Pharma Nasal Spray Bidose System
  • Phoenix, Arizona
  • +33 more
Mar 25, 2021

Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Boston (TAZEMETOSTAT, Zandelisib)

Not yet recruiting
  • Relapsed Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Boston, Massachusetts
  • +1 more
Oct 28, 2022

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +8 more
Feb 10, 2022

Laparoscopic General, Gynecological and Urologic Surgeries Trial in Montréal-Est (To evaluate sevoflurane consumption when using

Completed
  • Laparoscopic General, Gynecological and Urologic Surgeries
  • To evaluate sevoflurane consumption when using Memsorb
  • To evaluate sevoflurane consumption when using classical Dräegersorb
  • Montréal-Est, Quebec, Canada
    Hopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montré
Jan 19, 2023

De-identified Data From Commercially-available App Lose It!

Completed
  • Overweight and Obesity
  • Lose It! commercial weight loss app
  • (no location specified)
Sep 28, 2022

Schizophrenia Spectrum Disorders Trial (Oxytocin, Placebo)

Not yet recruiting
  • Schizophrenia Spectrum Disorders
  • Oxytocin
  • Placebo
  • (no location specified)
Nov 13, 2023

Duchenne Muscular Dystrophy Trial in Chicago, Richmond, Calgary (Viltolarsen)

Enrolling by invitation
  • Duchenne Muscular Dystrophy
  • Chicago, Illinois
  • +2 more
Nov 12, 2021

Knee Osteoarthritis, Obesity Trial in Surabaya (Dextrose Solution, Normal Saline)

Recruiting
  • Knee Osteoarthritis
  • Obesity
  • Dextrose Solution
  • Normal Saline
  • Surabaya, East Java, Indonesia
    Rumah Sakit Umum Daerah Haji Provinsi Jawa Timur, Indonesia
Jul 20, 2023

Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR

Completed
  • Healthy
  • Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
  • +2 more
  • Cairo, Egypt
    Genuine Research Center GRC
Mar 2, 2023

Netherton Syndrome Trial in San Antonio (DS-2325a, Placebo)

Recruiting
  • Netherton Syndrome
  • San Antonio, Texas
    Worldwide Clinical Trials
Nov 29, 2022

Netherton Syndrome Trial in Miami (DS-2325a, Placebo)

Recruiting
  • Netherton Syndrome
  • Miami, Florida
    Quotient Sciences -Miami
Nov 8, 2022

Androgenetic Alopecia Trial in New City (NTAP)

Active, not recruiting
  • Androgenetic Alopecia
  • NTAP
  • New City, New York
    The Skin Center Dermatology Group
Nov 20, 2023